Literature DB >> 18077707

Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion.

Pablo Gastaminza1, Guofeng Cheng, Stefan Wieland, Jin Zhong, Wei Liao, Francis V Chisari.   

Abstract

Intracellular infectious hepatitis C virus (HCV) particles display a distinctly higher buoyant density than do secreted virus particles, suggesting that the characteristic low density of extracellular HCV particles is acquired during viral egress. We took advantage of this difference to examine the determinants of assembly, maturation, degradation, and egress of infectious HCV particles. The results demonstrate that HCV assembly and maturation occur in the endoplasmic reticulum (ER) and post-ER compartments, respectively, and that both depend on microsomal transfer protein and apolipoprotein B, in a manner that parallels the formation of very-low-density lipoproteins (VLDL). In addition, they illustrate that only low-density particles are efficiently secreted and that immature particles are actively degraded, in a proteasome-independent manner, in a post-ER compartment of the cell. These results suggest that by coopting the VLDL assembly, maturation, degradation, and secretory machinery of the cell, HCV acquires its hepatocyte tropism and, by mimicry, its tendency to persist.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18077707      PMCID: PMC2258938          DOI: 10.1128/JVI.02053-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Co-translational degradation of apolipoprotein B100 by the proteasome is prevented by microsomal triglyceride transfer protein. Synchronized translation studies on HepG2 cells treated with an inhibitor of microsomal triglyceride transfer protein.

Authors:  F Benoist; T Grand-Perret
Journal:  J Biol Chem       Date:  1997-08-15       Impact factor: 5.157

2.  Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins.

Authors:  T Sasaki; M Kishi; M Saito; T Tanaka; N Higuchi; E Kominami; N Katunuma; T Murachi
Journal:  J Enzyme Inhib       Date:  1990

3.  Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B.

Authors:  S J Yeung; S H Chen; L Chan
Journal:  Biochemistry       Date:  1996-10-29       Impact factor: 3.162

4.  An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells.

Authors:  H Jamil; D A Gordon; D C Eustice; C M Brooks; J K Dickson; Y Chen; B Ricci; C H Chu; T W Harrity; C P Ciosek; S A Biller; R E Gregg; J R Wetterau
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

5.  Formation of native hepatitis C virus glycoprotein complexes.

Authors:  V Deleersnyder; A Pillez; C Wychowski; K Blight; J Xu; Y S Hahn; C M Rice; J Dubuisson
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  Inhibition of the microsomal triglyceride transfer protein blocks the first step of apolipoprotein B lipoprotein assembly but not the addition of bulk core lipids in the second step.

Authors:  D A Gordon; H Jamil; R E Gregg; S O Olofsson; J Borén
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

7.  Insulin-mediated inhibition of apolipoprotein B secretion requires an intracellular trafficking event and phosphatidylinositol 3-kinase activation: studies with brefeldin A and wortmannin in primary cultures of rat hepatocytes.

Authors:  J D Sparks; T L Phung; M Bolognino; C E Sparks
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

Review 8.  The physiological and molecular regulation of lipoprotein assembly and secretion.

Authors:  Daniel A Blasiole; Roger A Davis; Alan D Attie
Journal:  Mol Biosyst       Date:  2007-07-16

9.  Regulated intracellular degradation of apolipoprotein B in semipermeable HepG2 cells.

Authors:  K Adeli
Journal:  J Biol Chem       Date:  1994-03-25       Impact factor: 5.157

10.  Virion-like structures in HeLa G cells transfected with the full-length sequence of the hepatitis C virus genome.

Authors:  M Mizuno; G Yamada; T Tanaka; K Shimotohno; M Takatani; T Tsuji
Journal:  Gastroenterology       Date:  1995-12       Impact factor: 22.682

View more
  216 in total

1.  Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinase.

Authors:  Jamel Mankouri; Philip R Tedbury; Sarah Gretton; Mair E Hughes; Stephen D C Griffin; Mark L Dallas; Kevin A Green; D Grahame Hardie; Chris Peers; Mark Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Activity-based protein profiling identifies a host enzyme, carboxylesterase 1, which is differentially active during hepatitis C virus replication.

Authors:  David R Blais; Rodney K Lyn; Michael A Joyce; Yanouchka Rouleau; Rineke Steenbergen; Nicola Barsby; Lin-Fu Zhu; Adrian F Pegoraro; Albert Stolow; David L Tyrrell; John Paul Pezacki
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

3.  Tetherin has negligible activity in restricting hepatitis C virus in hepatocytes.

Authors:  Li Ye; Xu Wang; Jieliang Li; Jinping Liu; Servio H Ramirez; Jianguo Wu; Wenzhe Ho
Journal:  Innate Immun       Date:  2011-09-22       Impact factor: 2.680

Review 4.  Hepatitis C virus: assembly and release of virus particles.

Authors:  Daniel M Jones; John McLauchlan
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

5.  Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3.

Authors:  Ketti G Oliveira; Fernanda M Malta; Ana C S S Nastri; Azzo Widman; Paola L Faria; Rúbia A F Santana; Venâncio A F Alves; Flair J Carrilho; João R R Pinho
Journal:  Med Microbiol Immunol       Date:  2015-08-14       Impact factor: 3.402

6.  Transient activation of the PI3K-AKT pathway by hepatitis C virus to enhance viral entry.

Authors:  Zhe Liu; Yongjun Tian; Keigo Machida; Michael M C Lai; Guangxiang Luo; Steven K H Foung; Jing-hsiung James Ou
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

7.  Determining the involvement and therapeutic implications of host cellular factors in hepatitis C virus cell-to-cell spread.

Authors:  Naina Barretto; Bruno Sainz; Snawar Hussain; Susan L Uprichard
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

8.  Exacerbated Apoptosis of Cells Infected with Infectious Bursal Disease Virus upon Exposure to Interferon Alpha.

Authors:  Liliana L Cubas-Gaona; Elisabet Diaz-Beneitez; Marina Ciscar; José F Rodríguez; Dolores Rodríguez
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

9.  Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation.

Authors:  Urtzi Garaigorta; Francis V Chisari
Journal:  Cell Host Microbe       Date:  2009-12-17       Impact factor: 21.023

10.  Apolipoprotein c1 association with hepatitis C virus.

Authors:  Jean-Christophe Meunier; Rodney S Russell; Ronald E Engle; Kristina N Faulk; Robert H Purcell; Suzanne U Emerson
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.